Skip to main content
Top
Published in: Investigational New Drugs 4/2016

01-08-2016 | PRECLINICAL STUDIES

Peloruside A, a microtubule-stabilizing agent, induces aneuploidy in ovarian cancer cells

Authors: Ariane Chan, A. Jonathan Singh, Peter T. Northcote, John H. Miller

Published in: Investigational New Drugs | Issue 4/2016

Login to get access

Summary

To ensure proper chromosome segregation, mitosis is tightly regulated by the spindle assembly checkpoint (SAC). Low concentrations of microtubule-stabilizing agents can induce aneuploid populations of cells in the absence of G2/M block, suggesting pertubation of the spindle checkpoint. We investigated the effects of peloruside A, a microtubule-stabilizing agent, on expression levels of several key cell cycle proteins, MAD2, BUBR1, p55CDC and cyclin B1. Synchronized 1A9 ovarian carcinoma cells were allowed to progress through the cell cycle in the presence or absence of peloruside A. Co-immunoprecipitation and Western blotting were used to probe the cell cycle kinetics of MAD2 and BUBR1 dissociation from p55CDC. Using confocal microscopy, we investigated whether premature dissociation of MAD2 and BUBR1 at low (40 nM) but not high (100 nM) concentrations of peloruside A was caused by defects in the attachment of chromosomes to the mitotic spindle. An increased frequency of polar chromosomes was observed at low concentrations of peloruside A, suggesting that an increased frequency of pseudo-metaphase cells, which are not detected by the spindle assembly checkpoint, may be underlying the induction of aneuploidy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253–265CrossRefPubMed Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253–265CrossRefPubMed
3.
go back to reference Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 20:1–15PubMed Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 20:1–15PubMed
4.
go back to reference Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP–dependent transporters. Nat Rev Cancer 2:48–58CrossRefPubMed Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP–dependent transporters. Nat Rev Cancer 2:48–58CrossRefPubMed
5.
go back to reference West LM, Northcote PT, Battershill CN (2000) Peloruside A: a potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp. J Organomet Chem 65:445–449CrossRef West LM, Northcote PT, Battershill CN (2000) Peloruside A: a potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp. J Organomet Chem 65:445–449CrossRef
6.
go back to reference Hood KA, West LM, Rouwé B, Northcote PT, Berridge MV, Wakefield SJ, Miller JH (2002) Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule stabilizing activity. Cancer Res 62:3356–3360PubMed Hood KA, West LM, Rouwé B, Northcote PT, Berridge MV, Wakefield SJ, Miller JH (2002) Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule stabilizing activity. Cancer Res 62:3356–3360PubMed
7.
go back to reference Gaitanos TN, Buey RM, Díaz F, Northcote PT, Teesdale-Spittle P, Andreu JM, Miller JH (2004) Peloruside A does not bind to the taxoid site on β-tubulin and retains its activity in multidrug-resistant cell lines. Cancer Res 64:5063–5067CrossRefPubMed Gaitanos TN, Buey RM, Díaz F, Northcote PT, Teesdale-Spittle P, Andreu JM, Miller JH (2004) Peloruside A does not bind to the taxoid site on β-tubulin and retains its activity in multidrug-resistant cell lines. Cancer Res 64:5063–5067CrossRefPubMed
8.
go back to reference Pryor DE, O'Brate A, Bilcer G, Díaz JF, Wang Y, Wang Y, Kabaki M, Jung MK, Andreu JM, Ghosh AK, Giannakakou P, Hamel E (2002) The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity. Biochemistry 41:9109–9115CrossRefPubMed Pryor DE, O'Brate A, Bilcer G, Díaz JF, Wang Y, Wang Y, Kabaki M, Jung MK, Andreu JM, Ghosh AK, Giannakakou P, Hamel E (2002) The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity. Biochemistry 41:9109–9115CrossRefPubMed
9.
go back to reference Prota AE, Bargsten K, Zurwerra D, Field JJ, Díaz JF, Altmann K-H, Steinmetz MO (2013) Molecular mechanism of action of microtubule-stabilizng agents. Science 339:587–590CrossRefPubMed Prota AE, Bargsten K, Zurwerra D, Field JJ, Díaz JF, Altmann K-H, Steinmetz MO (2013) Molecular mechanism of action of microtubule-stabilizng agents. Science 339:587–590CrossRefPubMed
10.
go back to reference Prota AE, Bargsten K, Northcote PT, Marsh M, Altmann K-H, Miller JH, Díaz JF, Steinmetz MO (2014) Structural basis of microtubule stabilization by laulimalide and peloruside A. Angew Chem Int Ed 53:1621–1625CrossRef Prota AE, Bargsten K, Northcote PT, Marsh M, Altmann K-H, Miller JH, Díaz JF, Steinmetz MO (2014) Structural basis of microtubule stabilization by laulimalide and peloruside A. Angew Chem Int Ed 53:1621–1625CrossRef
11.
go back to reference Musacchio A, Salmon ED (2007) The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8:379–393CrossRefPubMed Musacchio A, Salmon ED (2007) The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8:379–393CrossRefPubMed
12.
go back to reference Lara-Gonzalez P, Westhorpe FG, Taylor SS (2012) The spindle assembly checkpoint. Curr Biol 22:R966–R980CrossRefPubMed Lara-Gonzalez P, Westhorpe FG, Taylor SS (2012) The spindle assembly checkpoint. Curr Biol 22:R966–R980CrossRefPubMed
13.
14.
16.
17.
go back to reference Zachariae W, Nasmyth K (1999) Whose end is destruction: cell division and the anaphase-promoting complex. Genes Dev 13:2039–2058CrossRefPubMed Zachariae W, Nasmyth K (1999) Whose end is destruction: cell division and the anaphase-promoting complex. Genes Dev 13:2039–2058CrossRefPubMed
18.
go back to reference Peters JM (2006) The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol 7:644–656CrossRefPubMed Peters JM (2006) The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol 7:644–656CrossRefPubMed
19.
go back to reference Kallio M, Weinstein J, Daum JR, Burke DJ, Gorbsky GJ (1998) Mammalian p55CDC mediates association of the spindle checkpoint protein Mad2 with the cyclosome/anaphase-promoting complex, and is involved in regulating anaphase onset and late mitotic events. J Cell Biol 141:1393–1406CrossRefPubMedPubMedCentral Kallio M, Weinstein J, Daum JR, Burke DJ, Gorbsky GJ (1998) Mammalian p55CDC mediates association of the spindle checkpoint protein Mad2 with the cyclosome/anaphase-promoting complex, and is involved in regulating anaphase onset and late mitotic events. J Cell Biol 141:1393–1406CrossRefPubMedPubMedCentral
20.
go back to reference Sudakin V, Chan GK, Yen TJ (2001) Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 154:925–936CrossRefPubMedPubMedCentral Sudakin V, Chan GK, Yen TJ (2001) Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 154:925–936CrossRefPubMedPubMedCentral
22.
go back to reference Chen J-G, Horwitz SB (2002) Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res 62:1935–1938PubMed Chen J-G, Horwitz SB (2002) Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res 62:1935–1938PubMed
23.
go back to reference Chen J-G, Yang C-PH, Cammer M, Horwitz SB (2003) Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res 63:7891–7899PubMed Chen J-G, Yang C-PH, Cammer M, Horwitz SB (2003) Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res 63:7891–7899PubMed
24.
go back to reference Wilmes A, Rawson P, Peng L, McLauchlan D, Northcote PT, Jordan TW, Miller JH (2011) Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells. Investig New Drugs 29:544–553CrossRef Wilmes A, Rawson P, Peng L, McLauchlan D, Northcote PT, Jordan TW, Miller JH (2011) Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells. Investig New Drugs 29:544–553CrossRef
25.
go back to reference Ikui AE, Yang CP, Matsumoto T, Horwitz SB (2005) Low concentrations of taxol cause mitotic delay followed by premature dissociation of p55CDC from Mad2 and BubR1 and abrogation of the spindle checkpoint, leading to aneuploidy. Cell Cycle 4:1385–1388CrossRefPubMed Ikui AE, Yang CP, Matsumoto T, Horwitz SB (2005) Low concentrations of taxol cause mitotic delay followed by premature dissociation of p55CDC from Mad2 and BubR1 and abrogation of the spindle checkpoint, leading to aneuploidy. Cell Cycle 4:1385–1388CrossRefPubMed
26.
go back to reference Wilmes A, Hanna R, Heathcott R, Northcote PT, Atkinson PH, Bellows DS, Miller JH (2012) Chemical genetic profiling of the microtubule-targeting agent peloruside A in budding yeast Saccharomyces cerevisiae. Gene 497:140–146CrossRefPubMed Wilmes A, Hanna R, Heathcott R, Northcote PT, Atkinson PH, Bellows DS, Miller JH (2012) Chemical genetic profiling of the microtubule-targeting agent peloruside A in budding yeast Saccharomyces cerevisiae. Gene 497:140–146CrossRefPubMed
27.
go back to reference Best HA, Matthews JH, Heathcott RW, Hanna R, Leahy DC, Coorey NVC, Bellows DS, Atkinson PH, Miller JH (2013) Laulimalide and peloruside A inhibit mitosis of Saccharomyces cerevisiae by preventing microtubule depolymerisation-dependent steps in chromosome separation and nuclear positioning. Mol BioSyst 9:2842–2852CrossRefPubMed Best HA, Matthews JH, Heathcott RW, Hanna R, Leahy DC, Coorey NVC, Bellows DS, Atkinson PH, Miller JH (2013) Laulimalide and peloruside A inhibit mitosis of Saccharomyces cerevisiae by preventing microtubule depolymerisation-dependent steps in chromosome separation and nuclear positioning. Mol BioSyst 9:2842–2852CrossRefPubMed
28.
go back to reference Ikui AE, Furuya K, Yanagida M, Matsumoto T (2002) Control of localization of a spindle checkpoint protein, Mad2, in fission yeast. J Cell Sci 115:1603–1610PubMed Ikui AE, Furuya K, Yanagida M, Matsumoto T (2002) Control of localization of a spindle checkpoint protein, Mad2, in fission yeast. J Cell Sci 115:1603–1610PubMed
29.
go back to reference Cimini D, Howell B, Maddox P, Khodjakov A, Degrassi F, Salmon ED (2001) Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J Cell Biol 153:517–527CrossRefPubMedPubMedCentral Cimini D, Howell B, Maddox P, Khodjakov A, Degrassi F, Salmon ED (2001) Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J Cell Biol 153:517–527CrossRefPubMedPubMedCentral
30.
go back to reference Weaver BA, Bonday ZQ, Putkey FR, Kops GJ, Silk AD, Cleveland DW (2003) Centromere-associated protein-E is essential for the mammalian mitotic checkpoint to prevent aneuploidy due to single chromosome loss. J Cell Biol 162:551–563CrossRefPubMedPubMedCentral Weaver BA, Bonday ZQ, Putkey FR, Kops GJ, Silk AD, Cleveland DW (2003) Centromere-associated protein-E is essential for the mammalian mitotic checkpoint to prevent aneuploidy due to single chromosome loss. J Cell Biol 162:551–563CrossRefPubMedPubMedCentral
31.
go back to reference Singh AJ, Razzak M, Teesdale-Spittle P, Gaitanos TN, Wilmes A, Paterson I, Goodman JM, Miller JH, Northcote PT (2011) Structure-activity studies of the pelorusides: new congeners and semi-synthetic analogues. Org Biomol Chem 9:4456–4466CrossRefPubMed Singh AJ, Razzak M, Teesdale-Spittle P, Gaitanos TN, Wilmes A, Paterson I, Goodman JM, Miller JH, Northcote PT (2011) Structure-activity studies of the pelorusides: new congeners and semi-synthetic analogues. Org Biomol Chem 9:4456–4466CrossRefPubMed
32.
go back to reference Zacharaki P, Stephanou G, Demopoulos NA (2013) Comparison of the aneugenic properties of nocodazole, paclitaxel and griseofulvin in vitro. Centrosome defects and alterations in protein expression profiles. J Appl Toxicol 33:869–879CrossRefPubMed Zacharaki P, Stephanou G, Demopoulos NA (2013) Comparison of the aneugenic properties of nocodazole, paclitaxel and griseofulvin in vitro. Centrosome defects and alterations in protein expression profiles. J Appl Toxicol 33:869–879CrossRefPubMed
33.
go back to reference Lee H-S, Lee NC, Grimes BR, Samoshkin A, Kononenko AV, Bansal R, Masumoto H, Earnshaw WC, Kouprinal N, Larionov V (2013) A new assay for measuring chromosome instability (CIN) and identification of drugs that elevate CIN in cancer cells. BMC Cancer 13:252–264CrossRefPubMedPubMedCentral Lee H-S, Lee NC, Grimes BR, Samoshkin A, Kononenko AV, Bansal R, Masumoto H, Earnshaw WC, Kouprinal N, Larionov V (2013) A new assay for measuring chromosome instability (CIN) and identification of drugs that elevate CIN in cancer cells. BMC Cancer 13:252–264CrossRefPubMedPubMedCentral
34.
go back to reference Kanakkanthara A, Wilmes A, O'Brate A, Escuin D, Chan A, Gjyrezi A, Crawford J, Rawson P, Kivell B, Northcote PT, Hamel E, Giannakakou P, Miller JH (2011) Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes. Mol Cancer Ther 10:1419–1429CrossRefPubMedPubMedCentral Kanakkanthara A, Wilmes A, O'Brate A, Escuin D, Chan A, Gjyrezi A, Crawford J, Rawson P, Kivell B, Northcote PT, Hamel E, Giannakakou P, Miller JH (2011) Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes. Mol Cancer Ther 10:1419–1429CrossRefPubMedPubMedCentral
35.
go back to reference Chang DC, Xu N, Luo KQ (2003) Degradation of cyclin B is required for the onset of anaphase in mammalian cells. J Biol Chem 278:37865–37873CrossRefPubMed Chang DC, Xu N, Luo KQ (2003) Degradation of cyclin B is required for the onset of anaphase in mammalian cells. J Biol Chem 278:37865–37873CrossRefPubMed
36.
go back to reference Brito DA, Rieder CL (2006) Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol 16:1194–1200CrossRefPubMedPubMedCentral Brito DA, Rieder CL (2006) Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol 16:1194–1200CrossRefPubMedPubMedCentral
37.
go back to reference Brito DA, Yang Z, Rieder CL (2008) Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied. J Cell Biol 182:623–629CrossRefPubMedPubMedCentral Brito DA, Yang Z, Rieder CL (2008) Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied. J Cell Biol 182:623–629CrossRefPubMedPubMedCentral
38.
39.
go back to reference Taylor SS, Hussein D, Wang Y, Elderkin S, Morrow CJ (2001) Kinetochore localization and phosphorylation of the mitotic checkpoint components Bub1 and BubR1 are differentially regulated by spindle events in human cells. J Cell Sci 114:4385–4395PubMed Taylor SS, Hussein D, Wang Y, Elderkin S, Morrow CJ (2001) Kinetochore localization and phosphorylation of the mitotic checkpoint components Bub1 and BubR1 are differentially regulated by spindle events in human cells. J Cell Sci 114:4385–4395PubMed
40.
go back to reference Elowe S, Hümmer S, Uldschmid A, Li X, Nigg EA (2007) Tension-sensitive Plk1 phosphorylation on BubR1 regulates the stability of kinetochore microtubule interactions. Genes Dev 21:2205–2219CrossRefPubMedPubMedCentral Elowe S, Hümmer S, Uldschmid A, Li X, Nigg EA (2007) Tension-sensitive Plk1 phosphorylation on BubR1 regulates the stability of kinetochore microtubule interactions. Genes Dev 21:2205–2219CrossRefPubMedPubMedCentral
41.
go back to reference De Antoni A, Pearson CG, Cimini D, Canman JC, Sala V, Nezi L, Mapelli M, Sironi L, Faretta M, Salmon ED, Musacchio A (2005) The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint. Curr Biol 15:214–225CrossRefPubMed De Antoni A, Pearson CG, Cimini D, Canman JC, Sala V, Nezi L, Mapelli M, Sironi L, Faretta M, Salmon ED, Musacchio A (2005) The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint. Curr Biol 15:214–225CrossRefPubMed
42.
go back to reference Yu H (2006) Structural activation of Mad2 in the mitotic spindle checkpoint: the two-state Mad2 model versus the Mad2 template model. J Cell Biol 173:153–157CrossRefPubMedPubMedCentral Yu H (2006) Structural activation of Mad2 in the mitotic spindle checkpoint: the two-state Mad2 model versus the Mad2 template model. J Cell Biol 173:153–157CrossRefPubMedPubMedCentral
43.
go back to reference Chen RH (2002) BubR1 is essential for kinetochore localization of other spindle checkpoint proteins and its phosphorylation requires Mad1. J Cell Biol 158:487–496CrossRefPubMedPubMedCentral Chen RH (2002) BubR1 is essential for kinetochore localization of other spindle checkpoint proteins and its phosphorylation requires Mad1. J Cell Biol 158:487–496CrossRefPubMedPubMedCentral
44.
go back to reference Morrow CJ, Tighe A, Johnson VL, Scott MI, Ditchfield C, Taylor SS (2005) Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20. J Cell Sci 118:3639–3652CrossRefPubMed Morrow CJ, Tighe A, Johnson VL, Scott MI, Ditchfield C, Taylor SS (2005) Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20. J Cell Sci 118:3639–3652CrossRefPubMed
45.
go back to reference Cimini D, Moree B, Canman JC, Salmon ED (2003) Merotelic kinetochore orientation occurs frequently during early mitosis in mammalian tissue cells and error correction is achieved by two different mechanisms. J Cell Sci 116:4213–4225CrossRefPubMed Cimini D, Moree B, Canman JC, Salmon ED (2003) Merotelic kinetochore orientation occurs frequently during early mitosis in mammalian tissue cells and error correction is achieved by two different mechanisms. J Cell Sci 116:4213–4225CrossRefPubMed
46.
go back to reference Rieder CL, Cole RW, Khodjakov A, Sluder G (1995) The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores. J Cell Biol 130:941–948CrossRefPubMed Rieder CL, Cole RW, Khodjakov A, Sluder G (1995) The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores. J Cell Biol 130:941–948CrossRefPubMed
47.
go back to reference Jordan MA, Toso RJ, Thrower D, Wilson L (1993) Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci U S A 90:9552–9556CrossRefPubMedPubMedCentral Jordan MA, Toso RJ, Thrower D, Wilson L (1993) Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci U S A 90:9552–9556CrossRefPubMedPubMedCentral
48.
go back to reference Barisic M, Sousa RS, Tripathy SK, Magiera MM, Zaytsev AV, Pereira AL, Janke C, Grishchuk EL, Maiato H (2015) Microtubule detyrosination guides chromosomes during mitosis. Science 348:799–803CrossRefPubMedPubMedCentral Barisic M, Sousa RS, Tripathy SK, Magiera MM, Zaytsev AV, Pereira AL, Janke C, Grishchuk EL, Maiato H (2015) Microtubule detyrosination guides chromosomes during mitosis. Science 348:799–803CrossRefPubMedPubMedCentral
49.
go back to reference Gundersen GG, Khawaja S, Bulinksi JC (1987) Postpolymerization detyrosination of α-tubulin: a mechanism for subcellular differentiation of microtubules. J Cell Biol 105:251–264CrossRefPubMed Gundersen GG, Khawaja S, Bulinksi JC (1987) Postpolymerization detyrosination of α-tubulin: a mechanism for subcellular differentiation of microtubules. J Cell Biol 105:251–264CrossRefPubMed
50.
go back to reference Janssen A, Kops GJ, Medema RH (2009) Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proc Natl Acad Sci U S A 106:19108–19113CrossRefPubMedPubMedCentral Janssen A, Kops GJ, Medema RH (2009) Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proc Natl Acad Sci U S A 106:19108–19113CrossRefPubMedPubMedCentral
Metadata
Title
Peloruside A, a microtubule-stabilizing agent, induces aneuploidy in ovarian cancer cells
Authors
Ariane Chan
A. Jonathan Singh
Peter T. Northcote
John H. Miller
Publication date
01-08-2016
Publisher
Springer US
Published in
Investigational New Drugs / Issue 4/2016
Print ISSN: 0167-6997
Electronic ISSN: 1573-0646
DOI
https://doi.org/10.1007/s10637-016-0355-6

Other articles of this Issue 4/2016

Investigational New Drugs 4/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine